[HTML][HTML] Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis

…, JSF Zhang, DR Feikin, GA Mackenzie… - The Lancet, 2013 - thelancet.com
Background The annual number of hospital admissions and in-hospital deaths due to severe
acute lower respiratory infections (ALRI) in young children worldwide is unknown. We …

[HTML][HTML] Epidemiology of nasopharyngeal carriage of respiratory bacterial pathogens in children and adults: cross-sectional surveys in a population with high rates of …

GA Mackenzie, AJ Leach, JR Carapetis, J Fisher… - BMC infectious …, 2010 - Springer
Background To determine the prevalence of carriage of respiratory bacterial pathogens,
and the risk factors for and serotype distribution of pneumococcal carriage in an Australian …

[HTML][HTML] Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study

GA Mackenzie, PC Hill, DJ Jeffries… - The Lancet infectious …, 2016 - thelancet.com
Background Little information is available about the effect of pneumococcal conjugate vaccines
(PCVs) in low-income countries. We measured the effect of these vaccines on invasive …

[HTML][HTML] Impact of the introduction of pneumococcal conjugate vaccination on pneumonia in The Gambia: population-based surveillance and case-control studies

GA Mackenzie, PC Hill, SM Sahito… - The Lancet infectious …, 2017 - thelancet.com
Background Pneumococcal conjugate vaccines (PCVs) are used in many low-income
countries but their impact on the incidence of pneumonia is unclear. The Gambia introduced …

[HTML][HTML] The phylogeography and incidence of multi-drug resistant typhoid fever in sub-Saharan Africa

…, R Downing, UN Ikumapayi, GA Mackenzie… - Nature …, 2018 - nature.com
There is paucity of data regarding the geographical distribution, incidence, and phylogenetics
of multi-drug resistant (MDR) Salmonella Typhi in sub-Saharan Africa. Here we present a …

Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Salmonella Typhi genomes

…, MM Levine, RK Lingegowda, SP Luby, GA Mackenzie… - Elife, 2023 - elifesciences.org
Background: The Global Typhoid Genomics Consortium was established to bring together the
typhoid research community to aggregate and analyse Salmonella enterica serovar Typhi (…

[HTML][HTML] Global landscape review of serotype-specific invasive pneumococcal disease surveillance among countries using PCV10/13: the pneumococcal serotype …

…, CS Lara, ME León, T Lepp, GA Mackenzie… - Microorganisms, 2021 - mdpi.com
Serotype-specific surveillance for invasive pneumococcal disease (IPD) is essential for
assessing the impact of 10- and 13-valent pneumococcal conjugate vaccines (PCV10/13). The …

[HTML][HTML] Pneumococcal vaccination and otitis media in Australian Aboriginal infants: comparison of two birth cohorts before and after introduction of vaccination

GA Mackenzie, JR Carapetis, AJ Leach, PS Morris - BMC pediatrics, 2009 - Springer
Background Aboriginal children in remote Australia have high rates of complicated middle
ear disease associated with Streptococcus pneumoniae and other pathogens. We assessed …

[HTML][HTML] Upper airways colonisation of Streptococcus pneumoniae in adults aged 60 years and older: a systematic review of prevalence and individual participant data …

…, S Esposito, H Farida, R Kandasamy, GA Mackenzie… - Journal of Infection, 2020 - Elsevier
Background Colonisation with Streptococcus pneumoniae can lead to invasive pneumococcal
disease and pneumonia. Pneumococcal acquisition and prevalence of colonisation are …

[HTML][HTML] Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population …

GA Mackenzie, PC Hill, DJ Jeffries… - The Lancet Infectious …, 2021 - thelancet.com
Background The Gambia introduced seven-valent pneumococcal conjugate vaccine (PCV7)
in August 2009, followed by PCV13 in May, 2011, using a schedule of three primary doses …